Supporting ECPC’s work related to research projects and other activities involving the creation and dissemination of scientific information.
Prof. Giorgio Stanta of the University of Trieste is an expert in molecular pathology and diagnostics for oncology. He began his working career in molecular pathology in human tissues at the Department of Pathology of the Yale University (CT) working with some of the first groups developing molecular methodologies in human tissues. He is actively involved in many European organisations such as BBMRI.IT (Italian Biobanking Infrastructure), CEN (European Committee for Standardization) for molecular in-vitro diagnostic examinations, the European Society of Pathology (ESP) for the Molecular Pathology WG, the Organization of European Cancer Institutes (OECI) for the Biobanking and Molecular Pathobiology WG, the European Commission Initiative on Breast Cancer (ECIBC) and the European Molecular Pathology Master (EMPM) steering committee. He is involved in several active European projects such as the HERCULES project on high grade serous ovary carcinoma heterogeneity, the SPIDIA4P project on pre-analytical conditions of clinical material, and InstandNGS4P on the clinical evaluation of NGS commercially available products.
When I started my working career as a young pathologist I realized how complex it is to obtain useful information for the patients from cancer biopsies and how necessary is an evolution that involves the molecular characterization. I had then the privilege and the opportunity to work with some of the first scientists developing the molecular issue in cancer. From this onset the evolution was obvious and pressing. Today my major interest is to obtain standardized and reproducible molecular analyses in the clinical material to be exchangeable among European institutions and hospitals.
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages